1. Home
  2. PSNL

PSNL

Personalis Inc.

Logo Personalis Inc.

Health Care

Medical Specialities

Nasdaq

as 04-18-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

Founded: 2011 Country:
United States
United States
Employees: N/A City: FREMONT
Market Cap: 61.5M IPO Year: 2019
Target Price: $5.50 AVG Volume (30 days): 355.1K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.25 EPS Growth: N/A
52 Week Low/High: $0.89 - $3.27 Next Earning Date: 05-01-2024
Revenue: $73,481,000 Revenue Growth: 12.97%
Revenue Growth (this year): 2.86% Revenue Growth (next year): 15.89%

Share on Social Networks: